Vanguard holds 4,088,168 shares of QuidelOrtho (NASDAQ: QDEL)
Rhea-AI Filing Summary
QuidelOrtho Corp ownership filing: Vanguard Portfolio Management reports beneficial ownership of 4,088,168 shares of common stock, representing 6% of the class as of 03/31/2026. The filer reports 56,400 shares of sole voting power and sole dispositive power over 4,088,168 shares. The filing is signed on 04/29/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard holds a 6% stake in QuidelOrtho, primarily in dispositive control.
Vanguard Portfolio Management reports beneficial ownership of 4,088,168 shares, with sole dispositive power over the same amount and limited sole voting power of 56,400 shares. This pattern is typical when asset managers hold securities across multiple pooled funds or client accounts.
Ownership is reported under a Schedule 13G structure and reflects aggregator reporting across Vanguard entities; subsequent filings could show changes in percent ownership if positions shift.
Filing follows Schedule 13G aggregation rules and includes affiliate disclosure.
The filing cites SEC Release No. 34-39538 and clarifies that dispositive power is exercised by Vanguard Portfolio Management LLC and certain affiliates, including Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. The statement explains aggregated holdings across funds and managed accounts.
The document discloses that no single other person holds more than 5% and provides the issuer CUSIP 219798105 for precise identification.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
Sole dispositive power regulatory
CUSIP financial
AI-generated analysis. How Rhea-AI works. Not financial advice.